Of note, suppression of the TGFβ signalling pathway has previously been associated with resistance to CDK4/6 inhibitors through an extracellular miRNA-mediated mechanism in ER + breast cancer [58]. This evidence concerns the gene TGFB1 and breast carcinoma.